Nomogram for predicting survival after transjugular intrahepatic portosystemic shunt in portal hypertension patients with bleeding

Figure 1 Flowchart of this study. TIPS: Transjugular intrahepatic portosystemic shunt; HCC: Hepatocellular carcinoma.

Figure 2 Prognostic model predicting the 1-year and 2-year survival following transjugular intrahepatic portosystemic shunt. A: Forest plot of multivariable Cox regression analysis showing hazard ratios with 95% confidence interval; B: Nomogram predicting the 1-year and 2-year survival probabilities; C: Nomogram with a patient case example, illustrating predicted mortality probabilities at 1 year and 2 years. HR: Hazard ratio; CI: Confidence interval; AFP: Alpha-fetoprotein.

Figure 3 Receiver operating characteristic curves indicating the area under the curve for the nomogram model. A: Training set; B: Validation set. AUC: Area under the curve.

Figure 4 Calibration curves of the nomogram for predicting the 1-year and 2-year survival. A and B: Calibration curves of the nomogram for predicting the 1-year and 2-year survival in the training set; C and D: Calibration curves of the nomogram for predicting the 1-year and 2-year survival in the validation set.

Figure 5 Decision curve analysis for the nomogram predicting the mortality. A: Decision curve analysis for the nomogram predicting the mortality in the training set; B: Decision curve analysis for the nomogram predicting the mortality in the validation set. DCA: Decision curve analysis.

Figure 6 Kaplan-Meier survival curves comparing overall survival between high-risk and low-risk groups. A: Kaplan-Meier survival curves comparing overall survival between high-risk and low-risk groups in the training cohort; B: Kaplan-Meier survival curves comparing overall survival between high-risk and low-risk groups in the validation cohort.